Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (AMEX: ELI) announced today that the American Stock Exchange (“AMEX”) has confirmed that Elite has regained compliance with AMEX continued-listing standards.
Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (AMEX: ELI) announced today that the American Stock Exchange (“AMEX”) has confirmed that Elite has regained compliance with AMEX continued-listing standards.
